Je Hak Kim

Title: Je Hak Kim: Innovator in Pharmaceutical Composition

Introduction

Je Hak Kim is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy. With a total of 3 patents to his name, Kim's work is recognized for its potential impact on medical treatments.

Latest Patents

One of Kim's latest patents is a pharmaceutical composition containing fimasartan and hydrochlorothiazide. This invention provides a pharmaceutical composition with superior physical properties, as the main components exhibit excellent content uniformity. Additionally, he has developed a compound with angiogenesis inhibitory activity, which includes a preparation method and a pharmaceutical composition. This compound is particularly significant as it potently suppresses angiogenesis, making it applicable for the prevention and treatment of diseases linked to abnormal vascular endothelial growth factor activity.

Career Highlights

Kim is currently associated with Boryung Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to improving drug formulations and therapeutic outcomes.

Collaborations

Throughout his career, Kim has collaborated with esteemed colleagues, including Ji Han Kim and Kyung Wan Nam. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Je Hak Kim stands out as a prominent inventor in the pharmaceutical sector, with a focus on innovative compositions that address critical health challenges. His contributions are paving the way for advancements in medical treatments and improving patient outcomes.